| Product Code: ETC9615989 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Cell and Gene Therapy Manufacturing Services Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Cell and Gene Therapy Manufacturing Services Market - Industry Life Cycle |
3.4 Taiwan Cell and Gene Therapy Manufacturing Services Market - Porter's Five Forces |
3.5 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Taiwan Cell and Gene Therapy Manufacturing Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in cell and gene therapy technologies in Taiwan |
4.2.2 Growing demand for personalized medicine and advanced therapies |
4.2.3 Supportive government initiatives and regulatory framework for cell and gene therapy manufacturing services |
4.3 Market Restraints |
4.3.1 High cost of cell and gene therapy manufacturing services |
4.3.2 Limited expertise and skilled workforce in the field of advanced therapy manufacturing in Taiwan |
5 Taiwan Cell and Gene Therapy Manufacturing Services Market Trends |
6 Taiwan Cell and Gene Therapy Manufacturing Services Market, By Types |
6.1 Taiwan Cell and Gene Therapy Manufacturing Services Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 Taiwan Cell and Gene Therapy Manufacturing Services Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Oncology Diseases, 2021- 2031F |
6.2.3 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.4 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Orthopedic Diseases, 2021- 2031F |
6.2.5 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Ophthalmology Diseases, 2021- 2031F |
6.2.6 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Central Nervous System Disorder, 2021- 2031F |
6.2.7 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3 Taiwan Cell and Gene Therapy Manufacturing Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Clinical Manufacturing, 2021- 2031F |
6.3.3 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Commercial Manufacturing, 2021- 2031F |
6.4 Taiwan Cell and Gene Therapy Manufacturing Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.4.4 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Cell and Gene Therapy Manufacturing Services Market Import-Export Trade Statistics |
7.1 Taiwan Cell and Gene Therapy Manufacturing Services Market Export to Major Countries |
7.2 Taiwan Cell and Gene Therapy Manufacturing Services Market Imports from Major Countries |
8 Taiwan Cell and Gene Therapy Manufacturing Services Market Key Performance Indicators |
8.1 Number of collaborations and partnerships between Taiwanese companies and international biotech firms for technology transfer |
8.2 Percentage increase in the number of clinical trials using cell and gene therapies conducted in Taiwan |
8.3 Adoption rate of innovative manufacturing technologies in the cell and gene therapy sector in Taiwan |
9 Taiwan Cell and Gene Therapy Manufacturing Services Market - Opportunity Assessment |
9.1 Taiwan Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Taiwan Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Taiwan Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Taiwan Cell and Gene Therapy Manufacturing Services Market - Competitive Landscape |
10.1 Taiwan Cell and Gene Therapy Manufacturing Services Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Cell and Gene Therapy Manufacturing Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here